Citrome, Leslie

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence

Correll, C. U., Citrome, L., Haddad, P. M., Lauriello, J., Olfson, M., Calloway, S. M., & Kane, J. M. (2016) · The Journal of Clinical Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 372

Adjunctive Aripiprazole, Olanzapine, or Quetiapine for Major Depressive Disorder: An Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed

Citrome, L. (2010) · Postgraduate Medicine

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 226

Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy

Ward, K., & Citrome, L. (2019) · Neuropsychiatric Disease and Treatment

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 181

Chatbots, generative AI, and scholarly manuscripts: WAME recommendations on chatbots and generative artificial intelligence in relation to scholarly publications

Zielinski, C., Winker, M. A., Aggarwal, R., Ferris, L. E., Heinemann, M., Lapeña Jr, J. F., Pai, S. A., Ing, E., Citrome, L., Alam, M., et al. (2023) · Colombia Medica

Academic integrity and plagiarismPublishing and Scholarly Communication

Cited by 167

Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies

Czobor, P., Van Dorn, R. A., Citrome, L., Kahn, R. S., Fleischhacker, W. W., & Volavka, J. (2015) · European Neuropsychopharmacology

Schizophrenia research and treatmentMedication Adherence and Compliance

Cited by 112

The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out

Citrome, L. (2015) · International Journal of Clinical Practice

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 107

Activating and Sedating Adverse Effects of Second-Generation Antipsychotics in the Treatment of Schizophrenia and Major Depressive Disorder: Absolute Risk Increase and Number Needed to Harm

Citrome, L. (2017) · Journal of Clinical Psychopharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 92

Olanzapine Plasma Concentrations After Treatment With 10, 20, and 40 mg/d in Patients With Schizophrenia: An Analysis of Correlations With Efficacy, Weight Gain, and Prolactin Concentration

Citrome, L., Stauffer, V. L., Chen, L., Kinon, B. J., Kurtz, D. L., Jacobson, J. G., & Bergstrom, R. F. (2009) · Journal of Clinical Psychopharmacology

Schizophrenia research and treatmentPharmacogenetics and Drug Metabolism

Cited by 88

The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study

Citrome, L., Ota, A., Nagamizu, K., Perry, P., Weiller, E., & Baker, R. A. (2016) · International Clinical Psychopharmacology

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 74

Risk of Treatment-Emergent Diabetes Mellitus in Patients Receiving Antipsychotics

Citrome, L. L., Holt, R. I., Zachry, W. M., Clewell, J. D., Orth, P. A., Karagianis, J. L., & Hoffmann, V. P. (2007) · Annals of Pharmacotherapy

Schizophrenia research and treatmentDiabetes Treatment and Management

Cited by 64

The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?

Citrome, L., Stensbøl, T. B., & Maeda, K. (2015) · Expert Review of Neurotherapeutics

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 63

Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be hel

Citrome, L. (2015) · International Journal of Clinical Practice

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 63

Chatbots, generative AI, and scholarly manuscripts: WAME recommendations on chatbots and generative artificial intelligence in relation to scholarly publications

Zielinski, C., Winker, M. A., Aggarwal, R., Ferris, L. E., Heinemann, M., Lapeña, J. F., Pai, S. A., Ing, E., Citrome, L., Alam, M., et al. (2024) · Current Medical Research and Opinion

Academic Writing and PublishingPublishing and Scholarly Communication

Cited by 59

Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia

Hard, M. L., Mills, R. J., Sadler, B. M., Turncliff, R. Z., & Citrome, L. (2017) · Journal of Clinical Psychopharmacology

Schizophrenia research and treatmentPharmaceutical studies and practices

Cited by 51

Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder

Ward, K., & Citrome, L. (2018) · Expert Opinion on Drug Metabolism & Toxicology

Eating Disorders and BehaviorsPharmacology and Obesity Treatment

Cited by 32

Chatbots, ChatGPT, and Scholarly Manuscripts WAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications

Zielinski, C., Winker, M., Aggarwal, R., Ferris, L., Heinemann, M., Lapeña, Jr., Pai, S., Ing, E., & Citrome, L. (2023) · Open Access Macedonian Journal of Medical Sciences

Publishing and Scholarly CommunicationAcademic Writing and Publishing

Cited by 29

The importance of a good night's sleep: An open-label trial of the sodium salt of γ-hydroxybutyric acid in insomnia associated with schizophrenia

Kantrowitz, J. T., Oakman, E., Bickel, S., Citrome, L., Spielman, A., Silipo, G., Battaglia, J., & Javitt, D. C. (2010) · Schizophrenia Research

Sleep and related disordersSchizophrenia research and treatment

Cited by 21

Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA

Aigbogun, M. S., Liu, S., Kamat, S. A., Sapin, C., Duhig, A. M., & Citrome, L. (2018) · ClinicoEconomics and Outcomes Research

Schizophrenia research and treatmentHealth Systems, Economic Evaluations, Quality of Life

Cited by 18

Preclinical Evidence for the Use of Brexpiprazole + Antidepressant Treatment for Major Depressive Disorder and Post-Traumatic Stress Disorder: A Systematic Review

Brubaker, M., Kapadia, S., Maletic, V., Chambers, J., Watling, C., & Citrome, L. (2025) · Neuropsychiatric Disease and Treatment

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 7